Talk about large pharmaceutical companies buying small biotechnology firms is all the rage. The idea behind this talk is large companies have almost no pipeline of drugs and a tiny growth rate. They need to buy smaller companies with good drug pipelines to increase shareholder value. ...Continue reading here: http://bit.ly/zcCb0f
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.